Help Change
What’s Possible.
Your support advances potentially transformational science and helps expand access to personalized cancer care for patients who need more options.
I want to donate via:
Or, send a check to:
Cure-First
22125 17th Ave SE, Suite 117
Bothell, WA 98021
Why give?
-
✦
Advance Potentially
Transformational Science
Help accelerate research and discovery in functional precision oncology. -
✦
Expand Access to Personalized
Cancer Care
Help more patients benefit from individualized insights when treatment decisions are complex. -
✦
Turn Research Into Real-World Impact
Support the work that moves scientific discoveries closer to the patients and physicians who need them. -
✦
Fuel the Next Discovery
Help Cure First continue generating evidence, building collaborations, and exploring new possibilities in cancer care. -
✦
Put Patients at the Center
Support a nonprofit mission focused on advancing science in service of patients—not profits -
✦
Help Bring New Possibilities Within Reach
Help bridge the gap between promising scientific innovation and the patients who may benefit from it.
Frequently Asked Questions
-
Yes. Cure First is a 501(c)(3) nonprofit organization, and your donation is tax-deductible to the extent permitted by law. You will receive a donation receipt for your records.
-
Cure First, a registered 501(c)(3) nonprofit, is prepared to take stewardship of the PARIS Test. By supporting this effort, you help:
Keep the lab operational and maintain CLIA certification
Preserve the scientific team and clinical expertise
Protect the high-throughput testing platform
Expand access to more patients and enable broader clinical adoption
-
Absolutely! Cure First welcomes volunteers who want to help advance our mission and make a difference for patients and families facing cancer. To learn more about volunteer opportunities and other ways to get involved, contact us at paristest@cure-first.org.
-
Yes. A gift to Cure First can be a meaningful way to honor or remember someone special while supporting research and expanding access to personalized cancer care.